These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 3031799)
1. [Calcium antagonists--a new class of drugs used in the treatment of lung diseases (current status and outlook)]. Mihălţan F Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1986; 35(4):289-97. PubMed ID: 3031799 [No Abstract] [Full Text] [Related]
2. Current and potential indications for Ca2+ antagonists. Scriabine A Ration Drug Ther; 1987 Nov; 21(11):1-7. PubMed ID: 3328218 [No Abstract] [Full Text] [Related]
3. [Effectiveness of calcium antagonists in the treatment of patients with chronic nonspecific lung diseases]. Vereshchagina GN; Vasilenko GP; Kuleshova TV Klin Med (Mosk); 1988 Mar; 66(3):41-4. PubMed ID: 3392921 [No Abstract] [Full Text] [Related]
5. [Calcium antagonists in the treatment of cardiovascular diseases (review of the literature)]. Chekman IS; Nizhenkovskaia IV Vrach Delo; 1982 Sep; (9):47-52. PubMed ID: 6294997 [No Abstract] [Full Text] [Related]
6. Clinical differentiation of nifedipine and other calcium antagonists. Ebner F; Donath M; Rämsch KD Arq Bras Cardiol; 1984 Jul; 43(1):5-12. PubMed ID: 6395839 [No Abstract] [Full Text] [Related]
7. [Calcium antagonists in the treatment of heart failure. Re-evaluation of therapeutic strategies]. Gattis W; O'Connor CM Drugs; 2000; 59 Spec No 2():17-24. PubMed ID: 11002855 [TBL] [Abstract][Full Text] [Related]
8. Calcium channel antagonists. What do the second-generation agents have to offer? Salerno SM; Zugibe FT Postgrad Med; 1994 Jan; 95(1):181-90. PubMed ID: 8278298 [TBL] [Abstract][Full Text] [Related]
9. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study. Rejnmark L; Vestergaard P; Mosekilde L J Hypertens; 2006 Mar; 24(3):581-9. PubMed ID: 16467662 [TBL] [Abstract][Full Text] [Related]
10. Novel T-type calcium channel blockers: dioxoquinazoline carboxamide derivatives. Jo MN; Seo HJ; Kim Y; Seo SH; Rhim H; Cho YS; Cha JH; Koh HY; Choo H; Pae AN Bioorg Med Chem; 2007 Jan; 15(1):365-73. PubMed ID: 17035033 [TBL] [Abstract][Full Text] [Related]
15. Calcium antagonists in comparison: view of the pharmacologist. Borchard U J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S85-91. PubMed ID: 7898100 [TBL] [Abstract][Full Text] [Related]
16. New drugs, old drugs. Calcium antagonists. Moulds RF Med J Aust; 1997 Nov; 167(9):484-6. PubMed ID: 9397064 [No Abstract] [Full Text] [Related]
17. Calcium channel blockers. Dipalma JR Am Fam Physician; 1983 Feb; 27(2):283-5. PubMed ID: 6829383 [No Abstract] [Full Text] [Related]
18. [The role of calcium antagonists on coronary artery spasm and prevention of restenosis after angioplasty]. Kocurek A; Piwowarska W Przegl Lek; 1997; 54(1):37-42. PubMed ID: 9190633 [TBL] [Abstract][Full Text] [Related]
19. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers. Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127 [TBL] [Abstract][Full Text] [Related]